HealthEquity (HQY) director awarded 2,877 RSUs vesting by June 2027

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Gassen William reported acquisition or exercise transactions in this Form 4 filing.

HEALTHEQUITY, INC. director William Gassen received an award of 2,877 shares of common stock in the form of restricted stock units. Each unit represents a contingent right to one share of common stock. The restricted stock units vest in full on the earlier of June 25, 2027, or the date of the company’s next annual stockholder meeting in June 2027. After this grant, Gassen holds 3,611 shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gassen William

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,877	$0.00	--

Holdings After Transaction: Common Stock — 3,611 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant: 2,877 units Post-grant holdings: 3,611 shares Vesting date: June 25, 2027 +1 more

4 metrics

RSU grant 2,877 units Restricted stock unit award to director William Gassen

Post-grant holdings 3,611 shares Total common stock directly held after the award

Vesting date June 25, 2027 RSUs vest on earlier of this date or next annual meeting in June 2027

Grant price per share $0.00 Compensation-related award, no purchase price paid per unit

Key Terms

restricted stock unit, vest in full, annual stockholder meeting, grant, award, or other acquisition

4 terms

restricted stock unit financial

"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

vest in full financial

"The restricted stock units vest in full on the earlier of; (i) June 25, 2027, or (ii) the date of the issuer's next annual stockholder meeting in June 2027."

annual stockholder meeting financial

"The restricted stock units vest in full on the earlier of; (i) June 25, 2027, or (ii) the date of the issuer's next annual stockholder meeting in June 2027."

An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.

grant, award, or other acquisition financial

"Transaction code A is described as Grant, award, or other acquisition for this Form 4 entry."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/29/2026 - 04:37 PM Accepted by SEC EDGAR 06/29/2026 - 04:37 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gassen William

(Last)

(First)

(Middle)

C/O HEALTHEQUITY, INC.

15 W. SCENIC POINTE DR., STE. 100

(Street)

DRAPER

UTAH

84020

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/25/2026		A		2,877⁽¹⁾	A	$0	3,611	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the earlier of; (i) June 25, 2027, or (ii) the date of the issuer's next annual stockholder meeting in June 2027. Vested shares will be delivered to the reporting person upon vesting.

Remarks:

The Power of Attorney given by Mr. Gassen was previously filed with the U.S. Securities and Exchange Commission on March 30, 2026, as an exhibit to a statement on Form 3 filed by Mr. Gassen with respect to HealthEquity, Inc. and is hereby incorporated by reference.

	/s/ Michael Newton , Attorney-in-Fact	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did HEALTHEQUITY (HQY) director William Gassen report?

Director William Gassen reported receiving a grant of 2,877 restricted stock units of HEALTHEQUITY common stock. This is a compensation-related award, not an open-market purchase, and increases his directly held shares to 3,611 after the transaction.

How many HEALTHEQUITY (HQY) shares were granted to William Gassen?

William Gassen was granted 2,877 restricted stock units linked to HEALTHEQUITY common stock. Each unit represents the right to receive one share upon vesting, providing additional equity-based compensation as part of his role as a director.

When do William Gassen’s HEALTHEQUITY (HQY) restricted stock units vest?

The restricted stock units vest in full on the earlier of June 25, 2027, or the date of HEALTHEQUITY’s next annual stockholder meeting in June 2027. Once vested, shares will be delivered to Gassen at that time.

Is William Gassen’s HEALTHEQUITY (HQY) Form 4 transaction a stock purchase?

No. The Form 4 shows a grant of restricted stock units, coded as an acquisition (A), rather than an open-market stock purchase. These units are part of director compensation and convert into shares only when they vest in 2027.

How many HEALTHEQUITY (HQY) shares does William Gassen own after this grant?

Following the award of 2,877 restricted stock units, William Gassen’s direct holdings total 3,611 shares of HEALTHEQUITY common stock. This figure reflects his position immediately after the reported compensation grant.